ESG Report 2022/23
2022/23 highlights and recognitions
2022/23 sustainability highlights
Sonova has made significant achievements and progress on its targets during the 2022/23 financial year.
More than
17,600
employees worldwide (FTEs)
– 22%
scope 1, 2 and 3 greenhouse gas (CO2e) emissions vs. 20191
270
hearing care professionals trained in low- and middle-income countries through the SIHA program since 2021/22
100%
renewable electricity in our own operations worldwide
More than
54%
of our people managers are women
82%
employee engagement score in the annual HearMe survey
2/3
of our leaders are recruited internally
Submitted
SBTi
science-based reduction targets for scope 1, 2, and 3 CO2e emissions (pending validation)
More than
2,880
hearing aids fitted through Hear the World Foundation projects
10%
of the variable cash compensation of the Management Board is linked to ESG performance
We launched a new tool to assess sustainability risks for our suppliers and engage with them to improve their practices
More than
1,800
active granted patent and design rights owned by Sonova
- Including Sennheiser, our Consumer Hearing business and Alpaca for all years.
2022/23 recognitions, frameworks and initiatives supported
2022/23 highlights and recognitions
Sonova has been regularly and continuously recognized by various leading ESG rating agencies, and included in sustainability indices, including during the 2022/23 financial year. Sonovaʼs reporting on its ESG performance is made in accordance with several global reporting frameworks to enhance transparency and comparability.
ESG ratings & indices
Member of the Dow Jones Sustainability Indices since 2014; ranked 2nd out of 268 companies in the health care equipment and supplies industry in 2022.
Awarded the second-highest CDP score of ‘A-’ in 2022, placing Sonova in the top 12% of the medical equipment and supplies industry.
Rated “Prime” with a score of B in the 2022 ISS ESG Corporate Rating, placing Sonova in the top 2% of the health care equipment and supplies industry.
Included as a constituent company in the FTSE4Good Index Series since 2014, ranked in the top 10% of the health care sector.
Rated AA (on a scale of AAA-CCC) in the 2022 MSCI ESG Ratings assessment1.
Frameworks and initiatives supported
Sonovaʼs ESG Report has been prepared in accordance with Global Reporting Initiative (GRI) Standards since 2012/13.
Sonova has applied the Task Force on Climate-related Financial Disclosures (TCFD) framework for climate-related risk reporting since 2021/22.
Sonova has used the Sustainability Accounting Standards Board (SASB) standard for the medical equipment and supplies industry since 2020/21.
Since 2016, Sonova has been committed to the UN Global Compact corporate responsibility initiative and its principles in the areas of human rights, labor, environment and anti-corruption.
- The use by Sonova of any MSCI ESG Research LLC or its affiliates (“MSCI”) data, and the use of MSCI logos, trademarks, service marks or index names herein, do not constitute a sponsorship, endorsement, recommendation, or promotion of Sonova by MSCI. MSCI services and data are the property of MSCI or its information providers, and are provided ‘as-is’ and without warranty. MSCI names and logos are trademarks or service marks of MSCI.
